Beyond Stigma–Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction Recovery
Open accessThe DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index; 85 of the 131 sources its claims cite were checked for support.
Abstract
Addiction continues to be heavily stigmatized due to lingering misconceptions that frame substance use as a moral failing rather than a treatable neurobiological disorder. This stigma, when internalized, intensifies shame and obstructs recovery. Awareness Integration Theory, a multidisciplinary therapeutic model, addresses these internalized beliefs by identifying and integrating fragmented aspects of the self across thoughts, emotions, behaviors, and promotes self-awareness, emotional regulation, and cognitive restructuring, critical components in reducing shame and fostering resilience. This paper explores the interplay between self-perception, shame, resilience, and biological predisposition in addiction recovery. Research shows that shame-prone individuals are more likely to relapse, while guilt-prone individuals demonstrate greater capacity for change. Resilience, cultivated through self-forgiveness, social support, and neuroplastic interventions, mitigates the impact of shame. Genetic variants and epigenetic modifications influence reward deficiency syndrome, increasing vulnerability to addiction. The Genetic Addiction Risk Severity test can identify at-risk individuals, enabling precision-targeted interventions. Awareness Integration Therapy's integrative framework complements genomic and neurobiological insights by fostering self-acceptance, enhancing insight into unconscious belief systems, and motivating purposeful action. Neuroimaging studies support the role of resilience-based practices, including those embedded in Alcoholics Anonymous, in promoting dopamine homeostasis and neural recovery. In conclusion, stigma reduction must advance alongside personalized medicine. Integrating Awareness Integration Therapy with genetic screening, trauma-informed care, and psychoeducation offers a comprehensive, compassionate approach. Reframing addiction as a brain-based, treatable condition empowers clients and families, facilitating sustainable recovery grounded in science and self-awareness.
Overview
CoChat Summary
# TL;DR
This paper is a narrative review that argues addiction should be reframed as a brain-based, treatable condition rather than a moral failing, and that stigma reduction is central to recovery. It proposes combining genetic/epigenetic insight, dopamine-focused precision approaches, and Awareness Integration Therapy (AIT) to support resilience and relapse prevention.
# Key findings
- The paper states that internalized stigma intensifies shame, isolation, and reluctance to seek treatment, while shame-proneness is linked to higher relapse risk and guilt-proneness to greater capacity for change.
- It reports AIT outcomes from prior studies: a 76% reduction in depression, 60% reduction in anxiety, 43% improvement in self-esteem, and 20% increase in self-efficacy; a six-hour workshop produced 27.5% lower depression and 37% lower anxiety; and a self-help module reduced anxiety by 21.72% and depression by 68%.
- It summarizes genetic/epigenetic findings as supporting vulnerability to addiction through reward deficiency and dopamine dysregulation, citing a 59-gene enrichment analysis tied to dopaminergic pathways and noting that GARS is described as predictive of addiction severity.
- It notes that in a cited family case series, after receiving GARS results, family members reported reduced guilt and increased optimism for recovery, and prior work found four or more reward gene polymorphisms predict higher ASI scores for drug misuse while seven or more alleles predict severe alcoholism.
# Methods
- Narrative review / conceptual integration paper: it synthesizes prior clinical, genetic, neurobiological, and psychotherapeutic literature rather than presenting a new empirical trial.
- Data base: the paper draws on previously published studies, case series, and reviews, including reports on AIT, GARS, resilience, and epigenetic/genetic correlates of addiction.
- Main analysis: qualitative integration of evidence to build a framework linking stigma, shame, resilience, neurobiology, genetics, and AIT for addiction recovery and relapse prevention.
# Limitations
- The paper does not report a new original sample, control group, or statistical analysis of its own; this is evident from the text.
- It does not provide direct head-to-head evidence that the proposed combined model outperforms standard treatment; this is evident from the text.
- The paper’s claims about AIT, GARS, and precision behavioral management rely heavily on cited prior work and proposed frameworks rather than a single unified empirical test; this is evident from the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
62 Valid · 13 Not valid · 31 Not checked · 17 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Neuroimaging studies support the role of resilience-based practices, including those embedded in Alcoholics Anonymous, in promoting dopamine homeostasis and neural recovery.”
- Also stated in: § Resilience · boosted
“Functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) studies have demonstrated that resilience is associated with lower task-elicited neural activation in the basal ganglia and enhanced prefrontal cortex (PFC) activity, particularly in the context of relapse prevention during early abstinence from substance use.”
§ Beyond Stigma–Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction Recovery > Abstract
What the sources say
- Partly supportedcites [13] Charlet, 2018, Addiction sourceExperimental — accuracy not yet measured
The Results sections on PET studies and the Discussion link neuroimaging findings to dopaminergic markers of resilience and to brain recovery during abstinence. They do not show that resilience-based practices, including Alcoholics Anonymous practices, promote dopamine homeostasis or neural recovery. (LLM, conf=0.86)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Resilience · boosted
Every source the paper cites for this claim was checked and supports it.
In the paper
“Addiction can be conceptualized as a behavioral choice influenced by competing contingencies, especially sensitivity to immediate (NOW) versus delayed (LATER) rewards.24”
§ Beyond Stigma–Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction Recovery > Introduction > Neurogenetic & Epigenetic Correlates to Resilience and Stigma in Recovery
What the sources say
- Supportedcites [24] Lamb, 2016, Behav Processes source
The paper’s Abstract describes addiction as choice governed by competing contingencies and identifies sensitivity to delayed rewards as a factor. It contrasts the relatively immediate gains of drug use with the relatively remote gains of abstinence, matching the claim’s NOW-versus-LATER framing. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These traits are partially rooted in neurobiological variation, particularly dysfunctional dopaminergic signaling in the striatum and impaired prefrontal cortical regulation of subcortical emotional and motivational responses.20”
§ Beyond Stigma–Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction Recovery > Introduction > Neurogenetic & Epigenetic Correlates to Resilience and Stigma in Recovery
What the sources say
- Partly supportedcites [20] Yan, 2022, Mol Psychiatry sourceExperimental — accuracy not yet measured
The PFC network organization section (page unavailable) describes prefrontal projections that regulate reward seeking, and the Schizophrenia section reports that striatal D2-receptor overexpression in mice can disrupt inhibitory input to the PFC. The Dopamine section also links a dopamine-receptor variant to novelty seeking. These passages support parts of the proposed neurobiological account, but they do not establish that the unspecified traits arise from dysfunctional striatal dopamine signaling together with impaired prefrontal regulation of subcortical emotional and motivational responses. (LLM, conf=0.84)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) studies have demonstrated that resilience is associated with lower task-elicited neural activation in the basal ganglia and enhanced prefrontal cortex (PFC) activity, particularly in the context of relapse prevention during early abstinence from substance use.”
§ Beyond Stigma–Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction Recovery > Introduction > Resilience
What the sources say
- Partly supportedcites [13] Charlet, 2018, Addiction sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Variability in the mesolimbic system, due to genetic polymorphisms, may predispose individuals to heightened pain sensitivity or enhanced tolerance.27”
§ Beyond Stigma–Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction Recovery > Introduction > Neurogenetic & Epigenetic Correlates to Resilience and Stigma in Recovery
What the sources say
- Supportedcites [27] Chen, 2009, Med Hypotheses source
In “Dopamine D2 receptors and chronic pain” (page not provided), the authors hypothesize that low brain dopamine function may predispose people to low pain tolerance. In “Stress and pain” (page not provided), they say a DRD2 polymorphism can alter pain sensitivity. The claim preserves the paper’s tentative framing. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
53 more claims · 32 with their cited sources checked
Create a free account to see all 123 claims and every source verdict.
- Probably not a substantial claim. 39
- It may state two separate claims as one. 44
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Beyond Stigma–Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction Recovery > Introduction > Neurogenetic & Epigenetic Correlates to Resilience and Stigma in Recovery
“Their pharmacogenomic research using the Genetic Addiction Risk Score (GARS)”
§ Beyond Stigma–Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction Recovery > Abstract
“The Genetic Addiction Risk Severity test can identify at-risk individuals, enabling precision-targeted interventions.”
Citations
Cites
Allelic Association of Human Dopamine D2 Receptor Gene in Alcoholism
Blum, K. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440150063027 · Cited by 1,055 · cited 1×
“75 Since the identification of the DRD2 Taq A1 allele’s association with severe alcoholism in 1990, 15 the gene has been implicated across a spectrum of neuropsychiatric conditions.”
Self-citationNoble, E. P. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310066012 · Cited by 655
New concepts in cocaine addiction: The dopamine depletion hypothesis
Dackis, C. A., & Gold, M. S. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90022-3 · Cited by 607 · cited 1×
“22,23 Addiction can be conceptualized as a behavioral choice influenced by competing contingencies, especially sensitivity to immediate (NOW) versus delayed (LATER) rewards.”
Self-citationThe D 2 Dopamine Receptor Gene as a Determinant of Reward Deficiency Syndrome
Blum, K., Sheridan, P. J., Wood, R. C., Braverman, E. R., Chen, T. J. H., phd, J. G. C., & Comings, D. E. (1996) · Journal of the Royal Society of Medicine · doi:10.1177/014107689608900711 · Cited by 443 · cited 1×
“1 Stigma largely stems from outdated views that associate addiction, often linked to reward deficiency, 2 with moral weakness, rather than recognizing it as a chronic, relapsing, yet treatable brain disorder.”
Self-citationGraham, D. L., Edwards, S., Bachtell, R. K., DiLeone, R. J., Rios, M., & Self, D. W. (2007) · Nature Neuroscience · doi:10.1038/nn1929 · Cited by 401
Disrupting Reconsolidation of Drug Memories Reduces Cocaine-Seeking Behavior
Lee, J. L. C., Di Ciano, P., Thomas, K. L., & Everitt, B. J. (2005) · Neuron · doi:10.1016/j.neuron.2005.08.007 · Cited by 391
Social support and resilience to stress across the life span: A neurobiologic framework
Ozbay, F., Fitterling, H., Charney, D., & Southwick, S. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0049-7 · Cited by 303
Yan, Z., & Rein, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01092-3 · Cited by 300 · cited 1×
“20 A major advance in mapping genes implicated in addiction and reward deficiency syndromes has been led by Blum et al. Their pharmacogenomic research using the Genetic Addiction Risk Score (GARS) employed a multi-layered in silico approach encompassing: (1) Protein–Protein Interactions (PPIs), (2)…”
Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine
Liu, Q.-R., Lu, L., Zhu, X.-G., Gong, J.-P., Shaham, Y., & Uhl, G. R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.10.004 · Cited by 297
The Biology of Human Resilience: Opportunities for Enhancing Resilience Across the Life Span
Feder, A., Fred-Torres, S., Southwick, S. M., & Charney, D. S. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.07.012 · Cited by 269
Allelic association of the D2 dopamine receptor gene with cocaine dependence
Noble, E. P., Blum, K., Khalsa, M. E., Ritchie, T., Montgomery, A., Wood, R. C., Fitch, R. J., Ozkaragoz, T., Sheridan, P. J., Anglin, M. D., et al. (1993) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(93)90113-5 · Cited by 264
Self-citationEssential role for RGS9 in opiate action
Zachariou, V., Georgescu, D., Sanchez, N., Rahman, Z., DiLeone, R., Berton, O., Neve, R. L., Sim-Selley, L. J., Selley, D. E., Gold, S. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232594100 · Cited by 250
NOW vs LATER brain circuits: implications for obesity and addiction
Volkow, N. D., & Baler, R. D. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.04.002 · Cited by 237 · cited 1×
“24 Volkow and Baler 25 proposed a model in which dopamine modulates both phasic signaling (associated with NOW-oriented reward circuits) and tonic signaling (associated with LATER-oriented control circuits).”
Setting the standard for recovery: Physicians' Health Programs
DuPont, R. L., McLellan, A. T., White, W. L., Merlo, L. J., & Gold, M. S. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2008.01.004 · Cited by 227 · cited 1×
“11,12 Resilience and forgiveness offer a forward-looking and empowering framework for both prevention and early intervention.”
Self-citationAssociation of the A1 allele of the D2 dopamine receptor gene with severe alcoholism
Blum, K., Noble, E. P., Sheridan, P. J., Finley, O., Montgomery, A., Ritchie, T., Ozkaragoz, T., Fitch, R. J., Sadlack, F., Sheffield, D., et al. (1991) · Alcohol · doi:10.1016/0741-8329(91)90693-q · Cited by 213
Self-citationStigma and the Toll of Addiction
Volkow, N. D. (2020) · New England Journal of Medicine · doi:10.1056/nejmp1917360 · Cited by 206 · cited 2×
“Combating this stigma is essential to recovery, as highlighted by the American Society of Addiction Medicine (ASAM), the Addiction Policy Forum (APF), 3 and Volkow et al. 4 ASAM’s ethical guidelines for addiction medicine underscore the importance of respecting patient autonomy, delivering compassionate, nonjudgmental…”
Blum, K. (2018) · Frontiers in Bioscience · doi:10.2741/s518 · Cited by 143
Self-citationBDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal
Pu, L., Liu, Q.-S., & Poo, M. (2006) · Nature Neuroscience · doi:10.1038/nn1687 · Cited by 142
Covington, H. E., Kikusui, T., Goodhue, J., Nikulina, E. M., Hammer, R. P., & Miczek, K. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300587 · Cited by 138
Freeman, W. M., Patel, K. M., Brucklacher, R. M., Lull, M. E., Erwin, M. S., Morgan, D., Roberts, D. C. S., & Vrana, K. E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301577 · Cited by 130
Blum, K., Noble, E. P., Sheridan, P. J., Montgomery, A., Ritchie, T., Ozkaragoz, T., Fitch, R. J., Wood, R., Finley, O., & Sadlack, F. (1993) · Alcohol · doi:10.1016/0741-8329(93)90054-r · Cited by 123
Self-citationAlterations in BDNF and trkB mRNAs following acute or sensitizing cocaine treatments and withdrawal
Filip, M., Faron‐Górecka, A., Kuśmider, M., Gołda, A., Frankowska, M., & Dziedzicka‐Wasylewska, M. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.099 · Cited by 121
Genetic addiction risk score GARS trade a predictor of vulnerability to opioid dependence
Blum, K. (2018) · Frontiers in Bioscience · doi:10.2741/e816 · Cited by 104
Self-citationRegulation of RGS proteins by chronic morphine in rat locus coeruleus
Gold, S. J., Han, M., Herman, A. E., Ni, Y. G., Pudiak, C. M., Aghajanian, G. K., Liu, R., Potts, B. W., Mumby, S. M., & Nestler, E. J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02529.x · Cited by 99
Hellemans, K. G. C., Everitt, B. J., & Lee, J. L. C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3101-06.2006 · Cited by 98
Five-Year Recovery: A New Standard for Assessing Effectiveness of Substance Use Disorder Treatment
DuPont, R. L., Compton, W. M., & McLellan, A. T. (2015) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2015.06.024 · Cited by 95
Stanwood, G. D., Parlaman, J. P., & Levitt, P. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04970.x · Cited by 92
Managing shame and guilt in addiction: A pathway to recovery
Snoek, A., McGeer, V., Brandenburg, D., & Kennett, J. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.106954 · Cited by 92 · cited 2×
“6 A dominant view in the literature suggests guilt and shame have opposing behavioral impacts: guilt-prone individuals are more inclined to take corrective action and make amends, while those prone to shame may remain stuck in harmful behaviors, avoid accountability, or react with defensiveness.”
Kelly, J. F., Greene, M. C., & Abry, A. (2021) · Addiction · doi:10.1111/add.15333 · Cited by 88
Ostrander, M. M., Badiani, A., Day, H. E. W., Norton, C. S., Watson, S. J., Akil, H., & Robinson, T. E. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00247-1 · Cited by 87
Zavala, A. R., Osredkar, T., Joyce, J. N., & Neisewander, J. L. (2008) · Synapse · doi:10.1002/syn.20502 · Cited by 85
Danpanichkul, P., Díaz, L. A., Suparan, K., Tothanarungroj, P., Sirimangklanurak, S., Auttapracha, T., Blaney, H. L., Sukphutanan, B., Pang, Y., Kongarin, S., et al. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0835 · Cited by 85
Chen, A. L.-C., Chen, T. J. H., Waite, R. L., Reinking, J., Tung, H. L., Rhoades, P., Downs, B. W., Braverman, E., Braverman, D., Kerner, M., et al. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.07.059 · Cited by 84 · cited 1×
“27 32 Pharmacogenomic testing of candidate genes such as CB1, mu-opioid receptors, and proenkephalin may offer personalized treatment strategies and improved clinical outcomes.”
Self-citationHearing, M. C., Miller, S. W., See, R. E., & McGinty, J. F. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1090-2 · Cited by 82
David, S. P., Strong, D. R., Munafò, M. R., Brown, R. A., Lloyd-Richardson, E. E., Wileyto, P. E., Evins, A. E., Shields, P. G., Lerman, C., & Niaura, R. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701705027 · Cited by 80
David, S. P., Munafo, M. R., Murphy, M. F. G., Proctor, M., Walton, R. T., & Johnstone, E. C. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500447 · Cited by 79
Bachtell, R. K., Choi, K., Simmons, D. L., Falcon, E., Monteggia, L. M., Neve, R. L., & Self, D. W. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06199.x · Cited by 77
Dopamine D4 receptor polymorphism modulates cue-elicited heroin craving in Chinese
Shao, C., Li, Y., Jiang, K., Zhang, D., Xu, Y., Lin, L., Wang, Q., Zhao, M., & Li, J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0375-6 · Cited by 74
The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery
Blum, K., Thompson, B., Demotrovics, Z., Femino, J., Giordano, J., Oscar-Berman, M., Teitelbaum, S., Smith, D. E., Roy, A. K., Agan, G., et al. (2015) · Journal of Reward Deficiency Syndrome · doi:10.17756/jrds.2015-008 · Cited by 73
Self-citationBlum, K. (2013) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.1000139 · Cited by 73 · cited 1×
“72 Adolescence is a key period of vulnerability for addiction, during which environmental exposures can epigenetically activate or suppress inherited risk factors.”
Self-citationWiss, D. A., Avena, N., & Gold, M. (2020) · Nutrients · doi:10.3390/nu12113521 · Cited by 66
Self-citationSchmidt, E. D., Voorn, P., Binnekade, R., Schoffelmeer, A. N. M., & Vries, T. J. D. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04435.x · Cited by 65
The Formation and Function of the VTA Dopamine System
Hou, G., Hao, M., Duan, J., & Han, M.-H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073875 · Cited by 65 · cited 1×
“77 Loneliness, a growing public health concern, contributes significantly to both psychological and physical morbidity.”
Rundle, S. M., Cunningham, J. A., & Hendershot, C. S. (2021) · Drug and Alcohol Review · doi:10.1111/dar.13244 · Cited by 61
GABAA Receptors Containing ρ1 Subunits Contribute to In Vivo Effects of Ethanol in Mice
Blednov, Y. A., Benavidez, J. M., Black, M., Leiter, C. R., Osterndorff-Kahanek, E., Johnson, D., Borghese, C. M., Hanrahan, J. R., Johnston, G. A. R., Chebib, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085525 · Cited by 60 · cited 1×
“71 According to the American Society of Addiction Medicine (ASAM), individuals with SUDs suffer from impaired reward circuitry, often due to hypodopaminergic function caused by genetic or environmental factors.”
Li, Y., Shao, C., Zhang, D., Zhao, M., Lin, L., Yan, P., Xie, Y., Jiang, K., & Li, J. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30264 · Cited by 57
Itoh, K., Hashimoto, K., Shimizu, E., Sekine, Y., Ozaki, N., Inada, T., Harano, M., Iwata, N., Komiyama, T., Yamada, M., et al. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30097 · Cited by 56
Neurogenetics and Epigenetics in Impulsive Behaviour: Impact on Reward Circuitry
Archer, T., & Blum, K. (2012) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000115 · Cited by 54
Self-citationKlebaur, J. E., Ostrander, M. M., Norton, C. S., Watson, S. J., Akil, H., & Robinson, T. E. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03400-x · Cited by 51
Beneficial and detrimental effects of genetic explanations for addiction
Lebowitz, M. S., & Appelbaum, P. S. (2017) · International Journal of Social Psychiatry · doi:10.1177/0020764017737573 · Cited by 50
Suppression of ethanol withdrawal by dopamine
Blum, K., Eubanks, J. D., Wallace, J. E., & Schwertner, H. A. (1976) · Experientia · doi:10.1007/bf01920816 · Cited by 48
Self-citationStigma and Addiction: Being and Becoming
Buchman, D., & Reiner, P. B. (2009) · The American Journal of Bioethics · doi:10.1080/15265160903090066 · Cited by 48 · cited 1×
“83 93 Importantly, gender-specific stigma also plays a role; women more frequently cite stigma as a barrier to engaging in SUD group therapy, highlighting the need for gender-tailored treatment strategies.”
THE ROLE OF THE PHYSICIAN IN ADDICTION PREVENTION AND TREATMENT
Miller, N. S., & Sheppard, L. M. (1999) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70089-7 · Cited by 45 · cited 1×
“Similarly, Miller and Sheppard 5 argue that broader medical recognition of addiction as a treatable condition will improve understanding and reduce stigma surrounding diagnosis and treatment.”
van Roekel, E., Goossens, L., Scholte, R. H. J., Engels, R. C. M. E., & Verhagen, M. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02424.x · Cited by 44
Determinants of choice, and vulnerability and recovery in addiction
Lamb, R. J., Maguire, D. R., Ginsburg, B. C., Pinkston, J. W., & France, C. P. (2016) · Behavioural Processes · doi:10.1016/j.beproc.2016.04.001 · Cited by 43 · cited 1×
“24 Volkow and Baler 25 proposed a model in which dopamine modulates both phasic signaling (associated with NOW-oriented reward circuits) and tonic signaling (associated with LATER-oriented control circuits).”
Genetic and behavioral determinants of hippocampal volume recovery during abstinence from alcohol
Hoefer, M. E., Pennington, D. L., Durazzo, T. C., Mon, A., Abé, C., Truran, D., Hutchison, K. E., & Meyerhoff, D. J. (2014) · Alcohol · doi:10.1016/j.alcohol.2014.08.007 · Cited by 40 · cited 1×
“40 Serotonin (5-hydroxytryptamine or 5-HT) is another critical neurotransmitter implicated in SUD acquisition, persistence, and recovery.”
Alcoholism and the D2 Dopamine Receptor Gene
Blum, K. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.13.1547 · Cited by 39
Self-citationDevelopment and validation of the Reward Deficiency Syndrome Questionnaire (RDSQ-29)
Kótyuk, E., Urbán, R., Hende, B., Richman, M. J., Mägi, A., Király, O., Barta, C., Griffiths, M. D., Potenza, M. N., Badgaiyan, R. D., et al. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211069102 · Cited by 38
Self-citationGerecke, K. M., Kolobova, A., Allen, S., & Fawer, J. L. (2013) · Brain Research · doi:10.1016/j.brainres.2013.02.027 · Cited by 37
Blum, K., Han, D. C., Gupta, A., Baron, D. A., Braverman, E. R., Dennen, C. A., Kazmi, S., Llanos-Gomez, L., Badgaiyan, R. D., Elman, I., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091385 · Cited by 36
Self-citationWitt, S. H., Frank, J., Frischknecht, U., Treutlein, J., Streit, F., Foo, J. C., Sirignano, L., Dukal, H., Degenhardt, F., Koopmann, A., et al. (2020) · Addiction · doi:10.1111/add.15020 · Cited by 35
Imaging resilience and recovery in alcohol dependence
Charlet, K., Rosenthal, A., Lohoff, F. W., Heinz, A., & Beck, A. (2018) · Addiction · doi:10.1111/add.14259 · Cited by 29 · cited 1×
“13”
Polymorphisms of the serotonin transporter and receptor genes: susceptibility to substance abuse
Herman, A. I., & Balogh (2012) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s25864 · Cited by 28 · cited 1×
“41 Glutamatergic systems also play a significant role.”
A Role for Dynamin in Triggering Ethanol Tolerance
Krishnan, H. R., Al-Hasan, Y. M., Pohl, J. B., Ghezzi, A., & Atkinson, N. S. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01587.x · Cited by 28 · cited 1×
“Krishnan et al 68 demonstrated that shibire and Syntaxin 1A are required for the acquisition of rapid functional tolerance to ethanol.”
(2016) · PubMed · Cited by 28
Chronic cocaine reduces RGS4 mRNA in rat prefrontal cortex and dorsal striatum
Schwendt, M., Hearing, M. C., See, R. E., & McGinty, J. F. (2007) · Neuroreport · doi:10.1097/wnr.0b013e328240507a · Cited by 26
Why haven't we solved the addiction crisis?
Blum, K., Bowirrat, A., Llanos-Gomez, L., Downs, B. W., Bagchi, D., Barh, D., Modestino, E. J., Baron, D. A., McLaughlin, T., Thanos, P. K., et al. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120404 · Cited by 23 · cited 1×
“33 Central to this model is the “Reward Dysregulation Syndrome Solution System”, a six-hit paradigm designed to identify individuals at risk and address the root cause of addiction, dopaminergic dysregulation.”
Self-citationNeurogenetics and Epigenetics of Loneliness
Bowirrat, A., Elman, I., Dennen, C. A., Gondré-Lewis, M. C., Cadet, J. L., Khalsa, J., Baron, D., Soni, D., Gold, M. S., McLaughlin, T., et al. (2023) · Psychology Research and Behavior Management · doi:10.2147/prbm.s423802 · Cited by 23
Self-citationPennington, C. R., Monk, R. L., Heim, D., Rose, A. K., Gough, T., Clarke, R., Knibb, G., Patel, R., Rai, P., Ravat, H., et al. (2023) · Psychology of Addictive Behaviors · doi:10.1037/adb0000919 · Cited by 22
Blum, K., Steinberg, B., Gondré-Lewis, M. C., Baron, D., Modestino, E. J., Badgaiyan, R. D., Downs, B. W., Bagchi, D., Brewer, R., McLaughlin, T., et al. (2021) · Psychology Research and Behavior Management · doi:10.2147/prbm.s292958 · Cited by 20
Self-citationGenetic Addiction Risk and Psychological Profiling Analyses for “Preaddiction” Severity Index
Blum, K., Han, D. C., Bowirrat, A., Downs, B. W., Bagchi, D., Thanos, P. K., Baron, D. A., Braverman, E. R., Dennen, C. A., Gupta, A., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111772 · Cited by 20 · cited 1×
“37 In a recent study, Legaki et al 38 highlighted the genetic and environmental complexity of alcohol use disorder.”
Self-citationAwareness Integration: A New Therapeutic Model
Zeine, F. (2014) · International Journal of Emergency Mental Health and Human Resilience · doi:10.4172/1522-4821.1000111 · Cited by 19
Self-citationRey, C. N., Kurti, A. N., Badger, G. J., Cohen, A. H., & Heil, S. H. (2019) · Behavior Analysis in Practice · doi:10.1007/s40617-019-00345-6 · Cited by 17
Carta, A. R., Casal, C., Cadoni, C., Tronci, E., & Chiara, G. D. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06095.x · Cited by 16
Lewandrowski, K.-U., Sharafshah, A., Elfar, J., Schmidt, S. L., Blum, K., & Wetzel, F. T. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01466-5 · Cited by 16
Self-citationWomen's and men's experiences in group therapy for substance use disorders: A qualitative analysis
Sugarman, D. E., Meyer, L. E., Reilly, M. E., & Greenfield, S. F. (2022) · The American Journal on Addictions · doi:10.1111/ajad.13242 · Cited by 15
Dennen, C. A., Blum, K., Bowirrat, A., Thanos, P. K., Elman, I., Ceccanti, M., Badgaiyan, R. D., McLaughlin, T., Gupta, A., Bajaj, A., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111864 · Cited by 15 · cited 1×
“39 These findings underscore the value of genetic feedback in destigmatizing addiction and empowering families with actionable insight.”
Self-citationBlum, K., Bowirrat, A., Baron, D., Elman, I., Makale, M. T., Cadet, J. L., Thanos, P. K., Hanna, C., Ahmed, R., Gondre-Lewis, M. C., et al. (2024) · Gene & Protein in Disease · doi:10.36922/gpd.1966 · Cited by 14
Self-citationAltered Expression of Neuroplasticity-Related Genes in Alcohol Addiction and Treatment
Legaki, E., Dovrolis, N., Moscholiou, N., Koutromanos, I., Vasilopoulos, E., Dakanalis, A., Gazouli, M., & Tzavellas, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111349 · Cited by 14 · cited 1×
“37 In a recent study, Legaki et al 38 highlighted the genetic and environmental complexity of alcohol use disorder.”
F654A and K558Q Mutations in NMDA Receptor 1 Affect Ethanol‐Induced Behaviors in Drosophila
Troutwine, B., Park, A., Vélez-Hernández, M. E., Lew, L. K., Mihic, S. J., & Atkinson, N. S. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14215 · Cited by 12 · cited 1×
“42 Addiction impacts not only individuals but also entire communities and health systems.”
Edwards, K. M., Siller, L., Ullman, S. E., Lee, K. D. M., & Murphy, S. B. (2021) · Journal of Interpersonal Violence · doi:10.1177/0886260521991283 · Cited by 11 · cited 1×
“In one study, Edwards et al 8 used regression analysis to show that post-traumatic growth (PTG) was linked to lower depression levels and a stronger sense of community.”
Hanna, C., Yao, R., Sajjad, M., Gold, M. S., Blum, K., & Thanos, P. K. (2023) · Brain Sciences · doi:10.3390/brainsci13121705 · Cited by 11
Self-citationSummary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography
(2024) · Journal of Addiction Psychiatry · doi:10.17756/jap.2024-043 · Cited by 11
Self-citationLoçasso, F., Filho, H., Alvarenga, R., Schimidt, S., Fiorelli, F., Ramos, P., Leidersnaider, S., Blum, K., Lewandrowski, K.-U., Cunha-Junior, E., et al. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14080886 · Cited by 10
Self-citationCzarnecki, D., Ziółkowski, M., Chodkiewicz, J., Długosz, A., Feldheim, J., Waszkiewicz, N., Kułak-Bejda, A., Gorzkiewicz, M., Budzyński, J., Junkiert-Czarnecka, A., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245892 · Cited by 9 · cited 1×
“70 The GABAA receptor family, particularly receptors containing ρ1, ρ2, or ρ3 subunits, has been primarily studied in retinal tissue but is also expressed in multiple brain regions.”
Szutorisz, H., & Hurd, Y. L. (2022) · Neuron · doi:10.1016/j.neuron.2022.03.018 · Cited by 9
Serum BDNF levels increase during early drug withdrawal in alcohol and crack cocaine addiction
Ornell, F., Scherer, J. N., Schuch, J. B., Sordi, A. O., Halpern, S. C., Rebelatto, F. P., Bristot, G., Kapczinski, F., Roglio, V. S., Pechansky, F., et al. (2023) · Alcohol · doi:10.1016/j.alcohol.2023.04.001 · Cited by 9 · cited 1×
“75 Since the identification of the DRD2 Taq A1 allele’s association with severe alcoholism in 1990, 15 the gene has been implicated across a spectrum of neuropsychiatric conditions.”
Gold, M. S., Blum, K., Bowirrat, A., Pinhasov, A., Bagchi, D., A. Dennen, C., K. Thanos, P., Hanna, C., Lewandrowski, K.-U., Sharafshah, A., et al. (2024) · INNOSC Theranostics and Pharmacological Sciences · doi:10.36922/itps.1918 · Cited by 9
Self-citationKótyuk, E., Demetrovics, Z., Urbán, R., Czakó, A., Blum, K., Griffiths, M. D., Potenza, M. N., & Efrati, Y. (2025) · Addictive Behaviors Reports · doi:10.1016/j.abrep.2025.100598 · Cited by 7
Self-citationLi, Y., Re, G.-F., Zhao, Y., Kong, D., Mao, J.-H., Wang, K.-H., & Kuang, Y.-Q. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-450 · Cited by 6 · cited 1×
“82”
Zeine, F., Jafari, N., & Beach, L. (2017) · Mental Health in Family Medicine · doi:10.25149/1756-8358.1302013 · Cited by 5 · cited 1×
“96 A six-hour therapeutic workshop study (Zeine et al, 2017) further showed reductions in depression (27.5”
InfluentialSelf-citationExploring perceptions of genetic risk and the transmission of substance use disorders
Keller, A., Bosk, E. A., Mendez, A., Greenfield, B., Flynn, C., Everett, G., Julien, F., & Michael, M. (2024) · Addiction Science & Clinical Practice · doi:10.1186/s13722-024-00470-w · Cited by 5
Hendy, K. (2024) · Public Understanding of Science · doi:10.1177/09636625231190743 · Cited by 4
CNS Genes Implicated in Relapse
Kuntz‐Melcavage, K. L., Freeman, W. M., & Vrana, K. E. (2008) · Substance Abuse Research and Treatment · doi:10.4137/sart.s1042 · Cited by 3 · cited 1×
“43 See Table 1 Synaptic proteins involved in neuronal regulation are evolutionarily conserved targets of ethanol.”
Weitzman, E. R., Blakemore, L. M., Pierce, S. E., Kossowsky, J., & Levy, S. (2024) · AJPM Focus · doi:10.1016/j.focus.2023.100153 · Cited by 3 · cited 1×
“83 93 Importantly, gender-specific stigma also plays a role; women more frequently cite stigma as a barrier to engaging in SUD group therapy, highlighting the need for gender-tailored treatment strategies.”
(2024) · Journal of Addiction Psychiatry · doi:10.17756/jap.2024-045 · Cited by 3
Top Three Healthcare Trends in Orthopaedics Affecting Musculoskeletal Care in the Elderly
Lorio, M. P., Lewandrowski, K.-U., & Blum, K. (2025) · Current Aging Science · doi:10.2174/0118746098309054240721180720 · Cited by 2
Self-citationZeine, F. (2025) · Medical Research Archives · doi:10.18103/mra.v13i3.6294 · Cited by 2
Self-citationZeine, F., & Changizi, S. (2025) · Medical Research Archives · doi:10.18103/mra.v13i5.6513 · Cited by 2
Self-citationZeine, F., Jafari, N., Manoukian, E., & Blum, K. (2024) · Medical Research Archives · doi:10.18103/mra.v12i8.5702 · Cited by 1
Self-citationZarbakhsh, L., & Zeine, F. (2023) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/1046127
Self-citation
Research works printed but not linked: 6
- BLum, 2024, J Addict Psychiatry, 8, 1
- Zeine, 2024, J Addict Psychiatry, 8, 50
- Blum, 2016, Precis Med, 1, 18
- Zeine, 2016, Int J Emerg Ment Health Hum Resilience, 16, 60
- Madani, 2023, Int J Psychol Res, 5, 1
- Zarbakhsh, 2023, Int J Sci Res, 12, 73
Cited by
Kopańska, M., Trojniak, J., & Pąchalska, M. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1834391 · Cited by 1
“This approach effectively transitions the patient from a passive recipient of psychiatric care to an active, informed participant (Danzl et al., 2012; de Oliveira and Dias, 2023; Blum et al., 2026).”
Metadata
- Authors
- Blum, K., Gold, M., Jafari, N., Lewandrowski, K.-U., Sharafshah, A., Mohankumar, K., Lorio, M., Bowirrat, A., Pinhasov, A., Thanos, K., Elman, I., Baron, D., Dennen, C., Fuehrlein, B., Lewandrowski, A., Modestino, E., Thanos, P., & Zeine, F.
- Affiliations
- Eötvös Loránd University (HU)
- Washington University in St. Louis (US)
- The Chicago School (US)
- Hospital Universitário Gaffrée e Guinle (BR)
- Guilan University of Medical Sciences (IR)
- Ariel University (IL)
- University at Buffalo, State University of New York (US)
- Harvard University (US)
- Stanford Medicine (US)
- Thomas Jefferson University Hospital (US)
- Yale University (US)
- University of Southern California (US)
- Curry College (US)
- California State University, Long Beach (US)
- Corresponding author
- Zeine, Foojan
- ORCID
- Venue
- Psychology Research and Behavior Management
- Publisher
- Informa UK Limited
- Published
- 2026-02
- Volume
- Volume 19
- Pages
- 1-14
- ISSN
- 1179-1578 (ISSN-L)
- PMC
- PMC12911994
- OpenAlex
- W7128494032
- Cited by
- 1
- References
- 96
- Citations by year
- 2026: 1
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Psychology Research and Behavior Management (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Social Sciences › Psychology › Clinical Psychology › Gambling Behavior and Treatments
- Keywords
- addiction recovery, stigma, shame, resilience, self-forgiveness, genetic predisposition to addiction, epigenetics, reward deficiency syndrome, relapse, dopamine homeostasis, neuroplasticity, trauma-informed care, personalized medicine, substance use disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
